Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder

Author: Rupnow Marcia F.T.   Greenspan Andrew   Gharabawi Georges M.   Kosik-Gonzalez Colette   Zhu Young   Stahl Stephen M.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.23, Iss.11, 2007-11, pp. : 2815-2822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract